Recent machine-extracted executive movements from SEC 8-K Item 5.02 filings, source-linked. Every card cites the SEC source.
Showing 651–700 of 33810
the Company terminated the employment of each of Stephen From, the Company’s Chief Executive Officer, Adam Sachs, the Company’s President, Sammy Khalifa, the Company’s Chief Technology Officer, and Dr. Barry Greene, the Company’s Chief Medical Officer, effective as of the close of business on July 21, 2026.
the Company terminated the employment of each of Stephen From, the Company’s Chief Executive Officer, Adam Sachs, the Company’s President, Sammy Khalifa, the Company’s Chief Technology Officer, and Dr. Barry Greene, the Company’s Chief Medical Officer, effective as of the close of business on July 21, 2026.
each of the members of the Board (Joseph Doherty, Stephen From, Adam Sachs, Sammy Khalifa, David Ho, Victoria Carr-Brendel, and Fuad Ahmad), each provided notice of his or her decision to resign from the Board and all committees thereof, effective upon the filing of the Form 15 with the Securities and Exchange Commission (the “SEC”).
each of the members of the Board (Joseph Doherty, Stephen From, Adam Sachs, Sammy Khalifa, David Ho, Victoria Carr-Brendel, and Fuad Ahmad), each provided notice of his or her decision to resign from the Board and all committees thereof, effective upon the filing of the Form 15 with the Securities and Exchange Commission (the “SEC”).
each of the members of the Board (Joseph Doherty, Stephen From, Adam Sachs, Sammy Khalifa, David Ho, Victoria Carr-Brendel, and Fuad Ahmad), each provided notice of his or her decision to resign from the Board and all committees thereof, effective upon the filing of the Form 15 with the Securities and Exchange Commission (the “SEC”).
each of the members of the Board (Joseph Doherty, Stephen From, Adam Sachs, Sammy Khalifa, David Ho, Victoria Carr-Brendel, and Fuad Ahmad), each provided notice of his or her decision to resign from the Board and all committees thereof, effective upon the filing of the Form 15 with the Securities and Exchange Commission (the “SEC”).
the Company terminated the employment of each of Stephen From, the Company’s Chief Executive Officer, Adam Sachs, the Company’s President, Sammy Khalifa, the Company’s Chief Technology Officer, and Dr. Barry Greene, the Company’s Chief Medical Officer, effective as of the close of business on July 21, 2026.
the Company terminated the employment of each of Stephen From, the Company’s Chief Executive Officer, Adam Sachs, the Company’s President, Sammy Khalifa, the Company’s Chief Technology Officer, and Dr. Barry Greene, the Company’s Chief Medical Officer, effective as of the close of business on July 21, 2026.
each of the members of the Board (Joseph Doherty, Stephen From, Adam Sachs, Sammy Khalifa, David Ho, Victoria Carr-Brendel, and Fuad Ahmad), each provided notice of his or her decision to resign from the Board and all committees thereof, effective upon the filing of the Form 15 with the Securities and Exchange Commission (the “SEC”).
On July 20, 2026, Dr. Gregory M. Sullivan informed Tonix Pharmaceuticals Holding Corp. (the “Company”) that he will retire from his role as Chief Medical Officer of the Company, effective August 20, 2026.
On July 16, 2026, Kara Wilson notified the Board of Directors (the “Board”) of Paychex, Inc. (the “Company”) of her decision not to stand for re-election at the Company’s annual meeting of stockholders in 2026 (the “Annual Meeting”).
Effective on July 17, 2026, Debra DeFelice no longer serves as Chief Financial Officer (“CFO”), Treasurer, and Executive Vice President of the Company.
each member of the Company’s board of directors resigned from and ceased serving on the Company’s board of directors and any and all committees thereof.
each member of the Company’s board of directors resigned from and ceased serving on the Company’s board of directors and any and all committees thereof.
each member of the Company’s board of directors resigned from and ceased serving on the Company’s board of directors and any and all committees thereof.
each member of the Company’s board of directors resigned from and ceased serving on the Company’s board of directors and any and all committees thereof.
each member of the Company’s board of directors resigned from and ceased serving on the Company’s board of directors and any and all committees thereof.
each member of the Company’s board of directors resigned from and ceased serving on the Company’s board of directors and any and all committees thereof.
each member of the Company’s board of directors resigned from and ceased serving on the Company’s board of directors and any and all committees thereof.
each member of the Company’s board of directors resigned from and ceased serving on the Company’s board of directors and any and all committees thereof.
each member of the Company’s board of directors resigned from and ceased serving on the Company’s board of directors and any and all committees thereof.
each member of the Company’s board of directors resigned from and ceased serving on the Company’s board of directors and any and all committees thereof.
On July 20, 2026, Kemper Corporation (the “Company”) determined that Matthew A. Hunton will depart from his role as Executive Vice President and President, Kemper Auto, effective August 3, 2026.
In connection with an internal reorganization, effective July 31, 2026, the position of Executive Vice President and Chief Brand and Digital Officer is being eliminated, and accordingly, Lori Gustafson will separate from the Company.
Elliot Richmond resigned as the Chief Financial Officer of the Company, effective July 17, 2026.
each of Timothy Lowe and Charles Zeynel notified the Company of his resignation as a member of the Board
each of Timothy Lowe and Charles Zeynel notified the Company of his resignation as a member of the Board
On July 17, 2026, immediately following receipt of stockholder approval at the Special Meeting, Bari A. Harlam and Susan Lattmann resigned from the Board (the “ Board Resignations ”).
On July 17, 2026, immediately following receipt of stockholder approval at the Special Meeting, Bari A. Harlam and Susan Lattmann resigned from the Board (the “ Board Resignations ”).
Joshua Feldman, the Company’s Chief Financial Officer, and the Company entered into a Transition and Separation Agreement (the “ Feldman Agreement ”), pursuant to which Mr. Feldman agreed to remain with the Company as its Chief Financial Officer through September 4, 2026.
On July 17, 2026, Neuronetics, Inc. (the “Company”) and W. Andrew Macan, who has served as Executive Vice President, Chief Legal Officer, and Corporate Secretary and in various other similar capacities since January 21, 2020, entered into a Separation Agreement (the “Separation Agreement”).
On July 14, 2026, Randall A. Moritz resigned from his role as the Chief Operating Officer of Kingfish Holding Corporation (the “Company”) due to medical reasons effective on that same date.
Barbara Humpton will retire as Chief Executive Officer and as a director of the Company, effective on October 1, 2026
in connection with Mr. Pinkston’s June 23, 2026 termination of employment with the Company.
On July 15, 2026, Maureen J. Rude notified the Company’s Board of Directors of her decision to resign, for personal reasons, from the Company’s Board and the Board of Directors of the Bank, effective immediately.
On July 14, 2026, Lawrence G. Finch notified Everspin Technologies, Inc. (the “Company”) of his resignation from the Company’s board of directors (the “Board”), including as a member of the Board’s audit committee, effective August 4, 2026.
On July 13, 2026, Irene Becklund informed Hims & Hers Health, Inc. (the “Company”) of her intention to resign as Chief Accounting Officer and Principal Accounting Officer, effective as of October 9, 2026.
On July 17, 2026, Lindsay Corporation (the “Company”) announced that Sam Hinrichsen notified the Board of Directors of the Company of his intent to resign from his position as the Company’s Senior Vice President and Chief Financial Officer effective August 31, 2026 (the “Effective Date”).
In connection with the appointment of Ms. O’Donnell-Butner, Mr. Mike Nguyen resigned in his capacity as Chief Compliance Officer of the Company, effective as of July 8, 2026.
the Company accepted the resignations or removals by court order of Lei Zhang as Chief Executive Officer and Executive Director, Meihua Xu as President and Treasurer, and Minming Yang as Company Secretary.
the Company accepted the resignations or removals by court order of Lei Zhang as Chief Executive Officer and Executive Director
the Company accepted the resignations or removals by court order of Lei Zhang as Chief Executive Officer and Executive Director, Meihua Xu as President and Treasurer, and Minming Yang as Company Secretary.
On June 4, 2026, Alejandro Araujo notified TOFLA Megaline Inc. (the “Company”) of his resignation as a member of the Company’s Board of Directors (the “Board”), effective immediately upon delivery of his resignation letter.
Mr. Ajay Kumar Dhadha voluntarily resigned from his positions as Chairman of the Board of Directors and Director of the Company, effective June 30, 2026.
Mr. Guy Ofir voluntarily resigned from his positions as Chief Financial Officer, General Counsel, and Director of the Company, effective July 16, 2026.
On July 14, 2026, Sid Tool Co., Inc., a wholly-owned subsidiary of the Company, and Mr. Dongre entered into an Agreement and Release (the “Transition Agreement”) in connection with Mr. Dongre’s transition from his position as Senior Vice President, General Counsel and Corporate Secretary of the Company to Special Advisor of the Company, effective as of July 20, 2026
Ms. Ludgate’s resignation from the Board was for personal reasons and was not the result of any disagreement with the Company on any matter relating to the Company’s operations, policies or practices.
As reported in the Original Form 8-K, effective as of December 14, 2025 (the “Separation Date”), Craig Tooman agreed by mutual consent to end his employment with Silence Therapeutics plc (the “Company”).
On July 13, 2026, Shlomo Dovrat informed the Board of Directors (the “ Board ”) of Unity Software Inc. (the “ Company ”) of his intention to resign as a member of the Board of the Company.
Effective July 14, 2026, Upwork Inc.’s, or the Company’s, Chief Financial Officer and principal financial officer, Erica Gessert, will take a temporary medical leave.
Recent executive movements from 8-K Item 5.02 filings, source-linked. Cards are extracted by an LLM and gated to those whose source quote is present verbatim in the filing text. Coverage is best-effort while backfill and monitoring mature; this is not yet a full-market index. See methodology.